Search research articles
Contact Us
Filters
Showing results (181-190 of 266) with videos related to
Page
of 27
Sort By:
JAMA
|
September 19, 1980
Prolactin-secreting pituitary adenomas. III. Frequency and diagnosis in amenorrhea-galactorrhea
W R Keye, R J Chang, C B Wilson, et al.
Fertility and Sterility
|
May 1, 1995
Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)
L R Nelson, V Y Fujimoto, R B Jaffe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1992
Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women
J Rabinovici, P Rothman, S E Monroe, et al.
The Journal of Endocrinology
|
December 1, 1975
Cytoplasmic oestrogen receptor complex of female ovine pituitary: changes associated with the reproductive state and oestradiol treatment
P M Wise, A H Payne, F J Karsch, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1991
Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle
M R Fluker, L A Marshall, S E Monroe, et al.
Fertility and Sterility
|
March 1, 1994
Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free alpha subunit
M R Fluker, S E Monroe, L A Marshall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1994
In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action
J L Shifren, N Doldi, N Ferrara, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1978
Steroid production by definitive and fetal zones of the human fetal adrenal gland
M Serón-Ferré, C C Lawrence, P K Siiteri, et al.
Human Reproduction (Oxford, England)
|
September 1, 2000
Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis
N A Cataldo, D A Dumesic, P C Goldsmith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)
L Hu, C Zaloudek, G B Mills, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 266) with videos related to
Sort By:
Page
of 27
JAMA
|
September 19, 1980
Prolactin-secreting pituitary adenomas. III. Frequency and diagnosis in amenorrhea-galactorrhea
W R Keye, R J Chang, C B Wilson, et al.
Fertility and Sterility
|
May 1, 1995
Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)
L R Nelson, V Y Fujimoto, R B Jaffe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1992
Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women
J Rabinovici, P Rothman, S E Monroe, et al.
The Journal of Endocrinology
|
December 1, 1975
Cytoplasmic oestrogen receptor complex of female ovine pituitary: changes associated with the reproductive state and oestradiol treatment
P M Wise, A H Payne, F J Karsch, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1991
Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle
M R Fluker, L A Marshall, S E Monroe, et al.
Fertility and Sterility
|
March 1, 1994
Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free alpha subunit
M R Fluker, S E Monroe, L A Marshall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1994
In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action
J L Shifren, N Doldi, N Ferrara, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1978
Steroid production by definitive and fetal zones of the human fetal adrenal gland
M Serón-Ferré, C C Lawrence, P K Siiteri, et al.
Human Reproduction (Oxford, England)
|
September 1, 2000
Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis
N A Cataldo, D A Dumesic, P C Goldsmith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)
L Hu, C Zaloudek, G B Mills, et al.
Page
of 27